GNRSU Stock Crashes 99.99% on Pink Sheets, Cannabis Firm Faces Delisting Risk

GNRSU stock has collapsed to near-zero levels, trading at just $0.000001 on the PNK exchange. The Greenrose Holding Company Inc., a cannabis producer based in Amityville, New York, has lost 99.99% of its value. This catastrophic decline reflects severe operational and financial distress. The company’s market cap sits at just $13 USD with only 145 shares trading daily. GNRSU stock represents one of the most extreme penny stock failures in recent memory, signaling potential delisting and shareholder wipeout risks.

GNRSU Stock Price Collapse: What Happened

GNRSU stock has experienced a devastating 99.99% decline from its previous close of $0.15 USD. The stock now trades at $0.000001, making it functionally worthless. Year-to-date losses exceed 99.99%, with the stock hitting its 52-week low at the current price level. The year-high of $0.151 shows how far the stock has fallen in just months. Trading volume remains extremely thin at 145 shares daily, indicating virtually no buyer interest. This level of collapse typically precedes delisting from the PNK exchange and potential bankruptcy proceedings.

Financial Metrics Show Severe Distress in GNRSU Stock

The underlying financials reveal why GNRSU stock has become worthless. The company carries a debt-to-equity ratio of 1.57, indicating heavy leverage relative to shareholder equity. Working capital stands at negative $103.4 million, showing the company cannot cover short-term obligations. The current ratio of 0.21 means GNRSU has only 21 cents in current assets for every dollar of current liabilities. Tangible asset value is negative $116.3 million, suggesting the company’s real assets cannot cover its debts. These metrics explain the market’s complete loss of confidence in GNRSU stock and the company’s ability to survive.

Cannabis Industry Headwinds Impacting GNRSU Stock

Greenrose Holding Company operates in the drug manufacturing sector, specifically specialty and generic cannabis production. The broader cannabis industry has faced significant regulatory uncertainty and oversupply issues. Many cannabis producers have struggled with profitability despite growing demand. GNRSU stock’s collapse reflects both company-specific failures and sector-wide challenges. The company cultivates, processes, and packages medical cannabis products from its New York headquarters. However, regulatory restrictions on interstate commerce and banking access have crippled many cannabis firms. Track GNRSU on Meyka for real-time updates on this distressed security.

Market Sentiment and Trading Activity for GNRSU Stock

Trading activity in GNRSU stock has virtually ceased, with only 145 shares changing hands daily. This illiquidity makes it impossible for shareholders to exit positions at any meaningful price. The bid-ask spread is likely enormous, with buyers demanding pennies per share. Most retail brokers have delisted GNRSU stock from their platforms due to extreme risk. Institutional investors abandoned the stock long ago. The lack of analyst coverage and institutional interest confirms the market has written off GNRSU stock entirely. Any remaining shareholders face total loss of capital with minimal opportunity to sell.

Meyka AI Grade and Valuation Analysis

Meyka AI rates GNRSU with a grade of B based on a score of 63.44. This grade factors in S&P 500 benchmark comparison, sector performance, financial growth, key metrics, and analyst consensus. However, this rating appears outdated given the stock’s subsequent 99.99% collapse. The PE ratio of 0.00000895 and price-to-book ratio of 0.0000232 suggest the market values GNRSU stock at essentially zero. The enterprise value of $101.4 million vastly exceeds the market cap of $13, indicating severe distress. These grades are not guaranteed and we are not financial advisors. The valuation metrics confirm GNRSU stock has no investment merit.

Delisting Risk and Shareholder Implications

GNRSU stock faces imminent delisting from the PNK exchange due to minimum price requirements. Most exchanges require stocks to maintain prices above $0.01 USD. Trading at $0.000001, GNRSU stock violates these thresholds by orders of magnitude. Delisting would further restrict trading and accelerate shareholder losses. The company’s 910 full-time employees and $1.58 revenue per share suggest ongoing operations, but financial collapse appears inevitable. Shareholders holding GNRSU stock should prepare for total loss of investment. Bankruptcy proceedings could eliminate equity value entirely, leaving shareholders with nothing.

Final Thoughts

GNRSU stock represents a complete market failure, trading at $0.000001 after a 99.99% collapse. The Greenrose Holding Company Inc. faces severe financial distress with negative working capital of $103.4 million and a debt-to-equity ratio of 1.57. The company’s cannabis business cannot generate sufficient revenue to service its debt load. Trading volume has dried up to just 145 shares daily, making exits impossible for remaining shareholders. Delisting from the PNK exchange appears inevitable given the stock’s sub-penny pricing. Investors should avoid GNRSU stock entirely and consider it a total loss. The company’s operational challenges combined with sector headwinds have destroyed shareholder value completely. This case demonstrates the extreme risks of penny stocks and distressed cannabis companies.

FAQs

Disclaimer:

Stock markets involve risks. This content is for informational purposes only. Past performance does not guarantee future results. Meyka AI PTY LTD provides market analysis and data insights, not financial advice. Always conduct your own research and consider consulting a licensed financial advisor.